| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.3M | -22.3% |
| SG&A Expense | $2.5M | -13.1% |
| Operating Income | -$6.3M | +6.1% |
| Interest Expense | $9K | +19.7% |
| Net Income | -$6.3M | +6.2% |
| EPS (Basic) | -$0.40 | +20.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +11.0% |
| Current Assets | $5.6M | +9.2% |
| Total Assets | $5.6M | +9.2% |
| Current Liabilities | $395K | +30.3% |
| Stockholders' Equity | $5.2M | +7.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.6M | -11.3% |
| Financing Cash Flow | $5.1M | +31.9% |